Holdings in Company

By

Regulatory News | 12 Jun, 2024

Updated : 07:01

RNS Number : 0153S
Clean Power Hydrogen
12 June 2024
 

 

12 June 2024                                                                                             

Clean Power Hydrogen plc

("CPH2", the "Company" or the "Group")

Holdings in Company

CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE") has been informed that Dr Nigel Williamson has transferred 14,000,000 shares to The Nigel Williamson Family Trust.

 

Following the transaction, The Nigel Williamson Family Trust holds 5.22% interest in the Company and Dr Williamson retains 3.78% interest in the Company.

 

ENDS

 

For more information, please contact:

 

Clean Power Hydrogen plc

via Camarco

Jon Duffy, Chief Executive Officer


James Hobson, Chief Financial Officer




Cavendish Capital Markets Limited - NOMAD & Broker


Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778



Camarco PR

+ 44(0) 20 3757 4980

Billy Clegg


Owen Roberts


Lily Pettifar


 

To find out more, please visit: https://www.cph2.com

 

Overview of CPH2

CPH2 is the holding company of Clean Power Hydrogen Group Limited ("Clean Power") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEADKFFLLLEFA

Last news